Antibiotic treatment trials for secondary prevention of coronary artery disease events.
Grayston
J T
JT
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000209:etiology; D002690:Chlamydia Infections / Q000150:complications / Q000188:drug therapy*; D016993:Chlamydophila pneumoniae; D003327:Coronary Disease / Q000517:prevention & control*; D006801:Humans
D000900:Anti-Bacterial Agents